Fara Brasó-Maristany

2 articles listing Fara Brasó-Maristany in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy Nature Communications
2. Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 Nature Communications